I have been charting global market trends on the internet since 1996, focusing initially on Asia and the US and extending coverage in recent years to the whole world. I use classic tops and bottoms as expounded by Edwards and Magee. Over the last fifteen years I have foreseen the Asian Financial Crisis of 1997, the tech top of 2000, the subsequent bottom in 2003, the crash of 2008 and the subsequent bottom of April 2009.
born in 1943 east Germany. escaped and grew up in Stuttgart west Germany. i have a degree in hotel management. immigrated to the united states in 1964.was co owner of one of the most successful restaurant's in orange county NY. the (JOLLY ONION INN ) .I sold in 1985 and became a REAL ESTATE BROKER in NJ, PA and NY.at present I am the co- owner of PRUDENTIAL GROSS & JANSEM HIGHLANDS REALTY in Sussex county Vernon NJ .gross Jansen.com
Phil is a practicing Registered Pharmacist who has over 30 years of experience in all aspects of the Pharmaceutical Industry with a core expertise in Dermatology products including those focused in Aesthetic Medicine. Phil started his career in Sales with Eli Lilly and Co. Phil went on to hold Executive Sales, Marketing and Administrative positions at Glaxo Inc. (now GSK) and Fujisawa (now Astellas). Phil first became involved in Dermatology/Aesthetic Medicine while V.P. General Manager North America at ICN Pharmaceuticals (now Valeant) where he managed the Dermatology Portfolio including the glycolic acid based line Glyderm. While at ICN, Phil led the licensing, branding and launch effort of Kinerase®, the most successful single entity cosmetic based line in the U.S. at the time. At ICN Phil also led the re-introduction of Efudex® after its acquisition from Roche and took sales from $14M to $60M in three years. Phil went on to be President and CEO of Obagi Medical Products (OMPI) where he doubled sales in 2 years and was responsible for adding the Vitamin C and tretinoin based products to the Obagi portfolio, as well as leading major expansions in to Japan and Western Europe. He then went on to be President and CEO of Randall International, then the premier provider of custom amenity and Spa products in the U.S. Phil maintains his own consulting business (Rose and Company) specializing in any aspect of the commercialization of prescription, OTC and cosmetic based products, with a focus on Dermatology Products.
As a consultant, Phil led the commercialization planning effort in the U.S. for Peplin Inc. with their novel ingenol mebutate compound in development for Rx treatment of Actinic Keratosis. Peplin was acquired by LEO. The product was approved by the FDA in 12/2011 and is marketed by LEO Pharmaceuticals as Picato®. www.picato.com
Phil is co-founder, Chief Marketing Officer and a Board Member of Peninsula Skincare Labs, Inc. Peninsula was founded in March 2011. Peninsula markets lines of Cosmetic and OTC skincare products for Skin Health/Anti-Ageing, Acne Vulgaris and Acne Rosacea through a novel distribution channel known as PAS (Pharmacist Assisted Sale). Phil successfully led the test marketing of the model and products in South Florida in 2011/2012 and is leading the effort for a National roll-out. www.nurigene.com
Phil is engaged in a consulting role with Pomega, Inc. for the commercial development and launch the PomegaMd and Pomega5 (novel Omega 5 Fatty Acid based products) line of products in to the Physician Dispensed and Prestige/Spa markets respectively. www.pomega5.com
Phil lives with his wife Beth in Fort Mitchell, KY. (Cincinnati, OH.)
Contact: email: firstname.lastname@example.org phone: 859-640-7003